Outcomes from haematological and locally advanced malignancy on critical care
Important chemotherapy drugs and regimes to be aware of
Diseases of oncotherapy: TLS, GVHD, etc
Managing the patient following a BMT
Sepsis in the immunosuppressed patient
ICU management of patients with haematological malignanciesarrow-up-right (BJAEd, Drs Beed and Levitt)
Hema-Icu study group reviewarrow-up-right
British Society of Haematology's guidelines for critical care managementarrow-up-right
Acute GVHDarrow-up-right and Tumour Lysis Syndromearrow-up-right (LITFL)
APLMarrow-up-right and Tumour Lysis Syndromearrow-up-right (IBCC)
Anaesthetic implications of chemotherapyarrow-up-right (BJAEd)
Immunotherapy on critical carearrow-up-right (IBCC)
Use of blood components guidelinearrow-up-right (AAGBI)
ICU complications of stem cell transplantarrow-up-right
Neutropaenic sepsisarrow-up-right (NICE CKS)
Know a great resource or teaching aid that we've missed? Let us knowarrow-up-right and help make this page even better.
Last updated 4 years ago
Was this helpful?